Similarly, CREB activity is positively associated with hepatic IR and NAFLD in mice (131) and its knockdown in mouse liver decreased hepatic and circulating lipid levels and improved insulin sensitivity (132). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.